m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00695)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
PHF10
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Zinc finger CCCH domain-containing protein 13 (ZC3H13) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by ZC3H13 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: ZC3H13-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: -1.07E+00 p-value: 1.29E-67 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | DNA damage repair is a major barrier for chemotherapy efficacy of pancreatic cancer, it's the first time that PHD finger protein 10 (PHF10) was found and involved in the DNA damage response. ZC3H13 knockdown downregulated the m6A methylation of PHF10 and decreased PHF10 translation in a YTHDF1-dependent manner. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Pathway Response | Homologous recombination | hsa03440 | ||
Cell Process | Homologous recombination | |||
DNA double strand breaks | ||||
In-vitro Model | PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
hTERT-HPNE | Normal | Homo sapiens | CVCL_C466 | |
DR-GFP-U2OS (DR-GFP-U2OS cells used for HR assay were generously provided by Huang Lab (Zhejiang University)) | ||||
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | DNA damage repair is a major barrier for chemotherapy efficacy of pancreatic cancer, it's the first time that PHD finger protein 10 (PHF10) was found and involved in the DNA damage response. ZC3H13 knockdown downregulated the m6A methylation of PHF10 and decreased PHF10 translation in a YTHDF1-dependent manner. | |||
Responsed Disease | Pancreatic cancer [ICD-11: 2C10] | |||
Target Regulator | Zinc finger CCCH domain-containing protein 13 (ZC3H13) | WRITER | ||
Target Regulation | Down regulation | |||
Pathway Response | Homologous recombination | hsa03440 | ||
Cell Process | Homologous recombination | |||
DNA double strand breaks | ||||
In-vitro Model | PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
hTERT-HPNE | Normal | Homo sapiens | CVCL_C466 | |
DR-GFP-U2OS (DR-GFP-U2OS cells used for HR assay were generously provided by Huang Lab (Zhejiang University)) | ||||
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |